Results 31 to 40 of about 110,333 (306)

Imbalance of Drug Transporter-CYP450s Interplay by Diabetes and Its Clinical Significance

open access: yesPharmaceutics, 2020
The pharmacokinetics of a drug is dependent upon the coordinate work of influx transporters, enzymes and efflux transporters (i.e., transporter-enzyme interplay). The transporter–enzyme interplay may occur in liver, kidney and intestine.
Yiting Yang, Xiaodong Liu
doaj   +1 more source

Drug-Drug Interactions at Organic Cation Transporter 1

open access: yesFrontiers in Pharmacology, 2021
The interaction between drugs and various transporters is one of the decisive factors that affect the pharmacokinetics and pharmacodynamics of drugs. The organic cation transporter 1 (OCT1) is a member of the Solute Carrier 22A (SLC22A) family that plays
Shiwei Zhou   +5 more
doaj   +1 more source

Cimetidine as an Organic Cation Transporter Antagonist [PDF]

open access: yesThe American Journal of Pathology, 2010
This Correspondence relates to “Organic transporter 2 mediates cisplatin-induced oto- and nephrotoxicity and is a target for protective interventions” (Am J Pathol 2010, 176:1169–1180).
Hans, Ehrsson   +3 more
openaire   +2 more sources

Renal tubule transport of organic cations [PDF]

open access: yesAmerican Journal of Physiology-Renal Physiology, 1981
Transcellular active tubular transport of organic cations occurs in the proximal renal tubule in the direction of excretion. These organic cations may be primary, secondary, tertiary, or quaternary amines. Endogenous neurohumors such as choline and catecholamines and drugs such as morphine and tetraethylammonium are representative transportable ...
openaire   +2 more sources

Enantioselective Drug Recognition by Drug Transporters

open access: yesMolecules, 2018
Drug transporters mediate the absorption, tissue distribution, and excretion of drugs. The cDNAs of P-glycoprotein, multidrug resistance proteins (MRPs/ABCC), breast cancer resistance protein (BCRP/ABCG2), peptide transporters (PEPTs/SLC15), proton ...
Yuichi Uwai
doaj   +1 more source

Interactions of organophosphate flame retardants with human drug transporters

open access: yesEcotoxicology and Environmental Safety, 2023
Organophosphate flame retardants (OPFRs) are environmental pollutants of increasing interest, widely distributed in the environment and exerting possible deleterious effects towards the human health. The present study investigates in vitro their possible
Valentin Tastet   +6 more
doaj   +1 more source

Polyspecific organic cation transporters and their impact on drug intracellular levels and pharmacodynamics. [PDF]

open access: yesPharmacol Res, 2016
Most drugs are intended to act on molecular targets residing within a specific tissue or cell type. Therefore, the drug concentration within the target tissue or cells is most relevant to its pharmacological effect. Increasing evidences suggest that drug
Wagner DJ, Hu T, Wang J.
europepmc   +2 more sources

Prediction of human drug clearance and anticipation of clinical drug-drug interaction potential from in vitro drug transport studies [PDF]

open access: yes, 2014
A major concern in drug development is the characterization of new molecular entities (NMEs) with respect to their safety and efficacy. Both factors are determined by the drug’s exposure within the body which itself is affected by drug clearance ...
Kunze, Annett
core   +1 more source

Intestinal OCTN2- and MCT1-targeted drug delivery to improve oral bioavailability

open access: yesAsian Journal of Pharmaceutical Sciences, 2020
Various drug transporters are widely expressed throughout the intestine and play important roles in absorbing nutrients and drugs, thus providing high quality targets for the design of prodrugs or nanoparticles to facilitate oral drug delivery.
Gang Wang   +8 more
doaj   +1 more source

Comparative analysis of novel decynium-22 analogs to inhibit transport by the low-affinity, high-capacity monoamine transporters, organic cation transporters 2 and 3, and plasma membrane monoamine transporter. [PDF]

open access: yesEur J Pharmacol, 2019
Fraser-Spears R   +14 more
europepmc   +2 more sources

Home - About - Disclaimer - Privacy